Amicus Therapeutics leads in the treatment of lysosomal storage disorders.

Amicus Therapeutics Biopharmaceutical Company is located in Cranbury, New Jersey. However, in 2008 it grew into a larger firm and expanded from its original set up in Cranbury to a second research site in San Diego. The company was established by major investors including Canaan Partners, Radius Ventures, and New Enterprise Associates.The company`s therapeutical products development relies on the Chaperone Advanced Replacement Therapy (CHART) technology. It has also focused on the development of enzyme replacement therapies (ERTs).

 

Amicus Therapeutics establishes and develops drugs and medicines that treat lysosomal storage disorders, a rare disease. Unlike other types of treatments which focus on replacing defective enzymes, Amicus Therapeutics uses the small molecule pharmacological chaperones which bind to a victim`s defective proteins and help to restore their functions and activities in the body. In 2014 Amicus Therapeutics Biopharmaceutical Company had the extensive portfolio of small molecule pharmacological chaperones among all other pharmaceutical firms.

 

In 2014 they developed Migalastat, an advanced pharmacological chaperone for treating Fabry disease. The main aim of the product is to stabilize endogenous mutant alpha-galactosidase. In 2013 Amicus Therapeutics established enzyme replacement therapy for the treatment of a rare disease known as Pombe by use of candidate AT2220. They also developed another candidate, Plicera for the treatment of Gaucher disease.

 

Amicus Therapeutics Company used to rely on contract manufacturing alone since they had no capability and adequate resources to stand on their own (YahooFinance). It made the company fall into a financial crisis after termination of the collaboration agreement with The Shire in 2009. However, in 2010 Amicus Therapeutics received the grant worth $ 210, 300 from the Alzheimer`s Drug Discovery Foundation. By the end of the year 2015, the Amicus Therapeutics had acquired Scioderm for over $ 947 million in both cash and stock.

 

The Amicus Therapeutics biopharmaceutical firm has become a leading business and science driven in delivering meaningful benefits and healthcare to their patients globally. The company`s product pipeline and technology platform put in place positions the qualified and experienced staffs at the forefront of developing therapies to meet significant unmet needs for rare and orphan diseases. The company through research is determined to develop drugs for neurodegenerative diseases including Parkinson`s and Alzheimer`s.

More about Amicus Therapeutics on : https://www.indeed.com/q-Amicus-Therapeutics-l-Cranbury,-NJ-jobs.html

The impact of Osteo Relief Institute on Arthritis Management

About arthritis

Arthritis is one of the diseases that significantly affect the world today. Many people in the world today are suffering from this condition, and there seems to be no proper treatment at all. In the United States, about fifty million residents are suffering from this condition. One shocking fact is that most of these patients are women. A huge percentage of the victims are the elderly. Usually, the term Arthritis is a term that is used in reference to the problems that mostly affect the joint. Currently, research has discovered over 100 different types of this condition.

Osteoarthritis

Osteoarthritis is a type of arthritis where the joint tissues degenerate. The breaking down of these tissues leads to the joint bones touching each other since there are no tissues in between. Osteo Relief Institute has developed a way in which the pain resulting from this condition can be reduced. Since the tissues degenerate, the joints tend to swell, and this comes with a lot of pain. Through Osteo Relief Institute, the quality of life of these patients can be certain.

Risk factors

Families may have a history of developing Osteoarthritis. Old age comes with weaker bones especially if the diet is not very good. When adults have huge bodies, they tend to exert a lot of pressure on the joints leading to the condition. Currently, Osteo Relief Institute has come up with a plan to manage these conditions regardless of the cause.

The location of Osteo Relief Institute

Currently, the organization is located in Monmouth County in New Jersey. The institute has several clinics which operate on different levels of the condition. There is a group of professional physicians who take care of the patients. The clinics are arranged such that the most urgent cases are to be handled first. Usually, the available facility at Osteo Relief Institute is sufficient to handle all the arthritis cases presented. The patients are first usually advised to try all the available medical options before the complex procedures are sought. When the patients are taken for medical checkups, they are handled with care. The patients have to be educated on all the possible procedures.

Check out Osteo Relief Institute on | Facebook | LinkedIn | Manta